AIM is associated with a massive CD8 T-cell expansion; symptoms can vary greatly in severity from a mild short influenza-like illness to a more severe syndrome with sore throat, lymphadenopathy, splenomegaly, hepatomegaly, and debilitating fatigue lasting months (1, 2). The gene discussed is CD8A; the disease is Lymphadenopathy.